TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Global Pharma Consulting (GPC) AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
809
|
620
|
868 |
| Financial expenses |
10
|
2
|
0 |
| Earnings before taxes |
-10
|
-355
|
-125 |
| EBITDA |
-1
|
-353
|
-125 |
| Total assets |
570
|
482
|
734 |
| Current assets |
570
|
482
|
734 |
| Current liabilities |
523
|
425
|
602 |
| Equity capital |
47
|
57
|
132 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
8.2%
|
11.8%
|
18.0% |
| Turnover per employee |
809
|
620
|
868 |
| Profit as a percentage of turnover |
-1.2%
|
-57.3%
|
-14.4% |
| Return on assets (ROA) |
0%
|
-73.2%
|
-17.0% |
| Current ratio |
109.0%
|
113.4%
|
121.9% |
| Return on equity (ROE) |
-21.3%
|
-622.8%
|
-94.7% |
| Change turnover |
189
|
-248
|
-1,117 |
| Change turnover % |
30%
|
-29%
|
-56% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.